Lynch syndrome-associated chordoma with high tumor mutational burden and significant response to immune checkpoint inhibitors.
Shinojima N, Ozono K, Yamamoto H, Abe S, Sasaki R, Tomita Y, Kai A, Mori R, Yamamoto T, Uekawa K, Matsui H, Nosaka K, Matsuzaki H, Komohara Y, Mikami Y, Mukasa A.
Shinojima N, et al. Among authors: kai a.
Brain Tumor Pathol. 2023 Jul;40(3):185-190. doi: 10.1007/s10014-023-00461-w. Epub 2023 Apr 22.
Brain Tumor Pathol. 2023.
PMID: 37086325
Free PMC article.